Imara to present clinical data on imr-687 in sickle cell disease at the european hematology association (eha) annual congress

Oral presentation provides final results from 93-patient phase 2a trial and additional interim data from open label extension trial

ELVN Ratings Summary

ELVN Quant Ranking